SCLERO.ORG
Search
Scleroderma Newsroom
ISN News Manager: Jo Frowde
Autoimmune
Media Stories
Scleroderma
ISN/Website
Autoimmune Archive
2016: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2016 - 2015 - 2014 - 2013

March 2016 Autoimmune News

Risk of end–stage renal disease (ESRD) in systemic lupus erythematosus (SLE) patients: a nationwide population–based study. ESRD is more common in SLE than non–SLE patients in this insurance database. Wiley Online Library, 02/10/2016. (Also see Symptoms and Complications of Lupus)

Influence of TNF–α inhibition on oxidative stress of rheumatoid arthritis (RA) patients. The results of our study demonstrate that a good control of the disease with anti–TNF–α agents can reduce oxidative stress in RA patients. Rheumatismo, 02/11/2016. (Also see Causes of Rheumatoid Arthritis)

The role of biomechanical factors in ankylosing spondylitis (AS): the patient’s perspective. Patients report physical trauma, exercise and physiotherapy as potential triggers for AS symptoms and these findings further support the experimental evidence for the role of biomechanical factors in disease. Rheumatismo, 02/11/2016. (Also see Ankylosing Spondylitis)

Evaluation of a self–management patient education program for patients with fibromyalgia syndrome (FMS): study protocol of a cluster randomized controlled trial. The study evaluates the effectiveness of a self–management patient education program for patients with FMS in the context of inpatient rehabilitation. BMC Musculoskeletal Disorders, 02/03/2016. (Also see Fibromyalgia)

Experiences of Patients With Rheumatoid Arthritis. The purpose of this study was to explore the experiences and support needs of adult patients living with Rheumatoid arthritis and provided insights into the experiences and support needs of patients. Sage Journals, Clin Nurs Res, 02/09/2016. (Also see Rheumatoid Arthritis)

Endometriosis and systemic lupus erythematosus (SLE): a population-based case–control study. Findings suggest an association between endometriosis and SLE and studies with extended follow–up will be necessary to clarify whether this association is influenced by the timing and severity of endometriosis diagnosis. Sage Journals, Lupus 02/06/2016. (Also see Lupus in Overlap)

Physical activity, sleep quality, and self–reported fatigue across the adult lifespan. These results support the hypothesis that physical activity may be associated with sleep quality in older adults, and suggest that improved sleep may mitigate self–reported fatigue in older adults in a manner that is independent of activity. PubMed, Exp Gerontol, 02/04/2016. (Also see Sleep Disorders and Fatigue)

Impact of pulmonary disease on patient–reported outcomes (PRO) and patient–performed functional testing in systemic lupus erythematosus (SLE). The six–minute walk test (6MWT) may be a promising tool in the assessment of pulmonary disease, which is common in SLE and adversely impacts 6MWT distance and dyspnea without apparent influence on other PROs. PubMed, Lupus, 02/03/2016. (Also see Symptoms and Complications of Lupus)

Connective tissue disease (CTD) increases risk for cardiovascular problems. The findings show that CTD is associated with higher prevalence of atherosclerotic cardiovascular disease and these insights could be used to improve how patients with a wide range of connective tissue diseases are evaluated. University of Chicago Medical Center, 02/05/2016. (Also see Connective Tissue Disease)

Safety of treatments for primary Sjögren’s syndrome. Synthetic DMARDs have not shown much efficacy in earlier studies, while biologic DMARDs show promising results regarding efficacy and cause mostly mild adverse events. PubMed, Expert Opin Drug Saf, 01/25/2016. (Also see Treatments for Symptoms of Sjögren’s Syndrome and DMARDs)

Go to Autoimmune News: February 2016
 
Recent Donors
See ISN News for recent donors, including memorials for
Patricia Ann Black, Gayle Hedlin, and Janet Paulmenn.
 

SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to:

International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702 USA

Email [email protected] to request our Welcome email, or to report bad links or to update this page content.

TOLL FREE HOTLINE 800-564-7099
Free to U.S. and Canadian Callers. Ask for our Free Info Packet by mail or email!
Scleroderma, Pulmonary Arterial Hypertension, and related illnesses.
Privacy Policy.

 
The most important thing in the world to know about scleroderma is sclero.org!
Donate Now
Copyright 1998-2016, International Scleroderma Network. AKA Scleroderma from A to Z and SCLERO.ORG. All Rights Reserved.